Cite
HARVARD Citation
Albisetti, M. et al. (2018). Design and rationale for the DIVERSITY study: An open‐label, randomized study of dabigatran etexilate for pediatric venous thromboembolism. Research and practice in thrombosis and haemostasis. 2 (2), pp. 347-356. [Online].